Factors Predicting Total Free Flap Loss after Microsurgical Reconstruction Following the Radical Ablation of Head and Neck Cancers

Table 2

Characteristics of patients who developed total free flap failure.

	Sex	Age	Original disease	Primary surgery	Presurgical radiation (Gy)	Presurgical chemotherapy	Salvage surgery
1	F	68	Hypopharyngeal cancer (SCC ); pT2N1M0	Partial hypopharyngectomy; Neck resection Free forearm flap transfer	100	TXT 360 mg	Free jejunum flap transfer
2	M	76	Recurrent laryngeal cancer (SCC); pT4N2M0	Partial oral base resection,; Neck resection; Free RAMC flap transfer	65	—	PMMC flap
3	F	68	Recurrent hypopharyngeal cancer (SCC); pT2N1M0	Hypopharyngectomy; Neck resection; Free jejunum flap transfer	66	TXT 360 mg	Free jejunum flap transfer
4	M	57	Nesopharyngeal cancer (SCC); pT3N2bM0	TPLE,; Neck resection Free ALT flap transfer	65	CDDP 100 mg, 5Fu 500 mg	PMMC flap
5	F	26	Maxillary sarcoma pT3N2bM0	Radical maxillary resection,; Free scapular and LD MC flap transfer	65	CDDP 500 mg, TXT 300 mg	Free ALT flap
6	F	50	Olfactory neuroblastoma pT3N2bM0	Radical maxillary and skull base resection,; Orbitotomy Free RAMC flap transfer	—	—	Free ALT flap

SCC: squamous cell carcinoma. LD MC flap: latissimus dorsi musclocutaneous flap. PMMC flap: pectoralis major musclocutaneous flap.
TLPE: total laryngopharyngoesophagectomy. NR: neck resection. RAMC flap: rectus abdominal musclocutaneous flap. ALT flap: anterolateral thigh flap. CDDP: Cisplatin. TXT: docetaxel.